David Nieto
Directeur/Membre du Conseil chez Tiba Biotech LLC
Provenance du réseau au premier degré de David Nieto
Entité | Type d'entité | Industrie | |
---|---|---|---|
Tiba Biotech LLC
Tiba Biotech LLC BiotechnologyHealth Technology Tiba Biotech LLC is a company that specializes in advancing the RNA medicine field with an improved approach to nucleic acid delivery. The company is based in Cambridge, MA. The company has developed a fully biodegradable nanoparticle delivery platform for safer vaccines and therapeutics, as well as a computational RNA design for more potent gene expression. The company's goal is to achieve better patient outcomes through rational design, from gene to delivery method beyond vaccines. The company was founded in 2017 by Christian Mandl, Karl H. Ruping, Jasdave Chahal. Karl H. Ruping has been the CEO since 2017.
5
| Holding Company | Biotechnology | 5 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à David Nieto via son réseau personnel
Société | Secteur | Personnes liées | Poste principal |
---|---|---|---|
AgaMatrix, Inc.
AgaMatrix, Inc. Electronic Equipment/InstrumentsElectronic Technology AgaMatrix, Inc. develops and manufactures medical devices. It offers next generation blood glucose monitoring products for the diabetes market. The firm’s products include iBGStar Diabetes Manager and Zero-Click software. The company was founded by Sridhar G. Iyengar, Ian S. Harding and Sonny X. Vu in 2001 and is headquartered in Salem, NH. | Electronic Equipment/Instruments | Director/Board Member | |
Medical University of Vienna | College/University | Corporate Officer/Principal | |
Agrivida, Inc.
Agrivida, Inc. BiotechnologyHealth Technology Agrivida, Inc. engages in the provision of research and manufacture of enzymes. It focuses on enzymes that improve poultry and swine nutrition. The company was founded by R. Michael Raab and Jeremy Schley Johnson in 2002 and is headquartered in Medford, MA. | Biotechnology | Founder Consultant / Advisor | |
NOVARTIS AG | Pharmaceuticals: Major | Private Equity Investor | |
Boston University | College/University | Graduate Degree | |
Société Générale SA (Broker)
Société Générale SA (Broker) Investment Banks/BrokersFinance Société Générale SA (Broker) (Société Général CIB) is the brokerage division of Société Générale SA (EPA: GLE) in France. Headquartere din Paris, the firm was founded in 1864 and provides full spectrum of brokerage services specifically tailored for both retail and institutional investors. Société Général CIB also offers execution, clearing and prime services across the following asset classes: equities, FX, fixed income, commodities, and listed derivatives to almost 30 European brokers in more than 80 markets worldwide. | Investment Banks/Brokers | Private Equity Investor | |
Massachusetts Institute of Technology | College/University | Doctorate Degree | |
Colby College | College/University | Undergraduate Degree | |
University of Ottawa | College/University | Undergraduate Degree | |
The Pennsylvania State University | College/University | Graduate Degree | |
Princeton University | College/University | Doctorate Degree | |
University of Wisconsin | College/University | Undergraduate Degree | |
University of Vienna | College/University | Doctorate Degree | |
Merck Research Laboratories Massachusetts LLC
Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Part of Merck & Co., Inc., Merck Research Laboratories Massachusetts LLC is a pharmaceutical company that provides free medicines and adult vaccines to qualified patients through their Merck Patient Assistance Program. The private company is based in Boston, MA and is a part of Merck & Co., Inc. and its affiliates. The company also offers information about insurance coverage and financial assistance options for eligible patients. The company conducts clinical trials and provides medical information covering thousands of topics in all fields of medicine through their Merck Manuals. Additionally, they report on their commitment to operating responsibly to benefit society through their corporate responsibility program, which includes their environmental, social, and governance (ESG) report. Merck for Mothers is an initiative to create a world where no woman has to die giving life. | Pharmaceuticals: Major | Corporate Officer/Principal | |
incTANK Inc
incTANK Inc Investment ManagersFinance incTANK Inc (incTANK) is a venture capital firm founded in 1999 by Karl H. Ruping. The firm is headquartered in the Cambridge, Massachusetts. | Investment Managers | Founder Private Equity Investor Private Equity Investor | |
International Vaccine Institute
International Vaccine Institute Miscellaneous Commercial ServicesCommercial Services The International Vaccine Institute develops and distributes vaccines. The non-profit company is based in Seoul, South Korea. Jerome H. Kim has been the CEO of the South Korean company since 2015. | Miscellaneous Commercial Services | Consultant / Advisor | |
Themis Bioscience GmbH
Themis Bioscience GmbH Pharmaceuticals: MajorHealth Technology Themis Bioscience GmbH operates as a biotechnology company, which engages in the development of prophylactic vaccinations from preclinical to early clinical phase. The firm focuses on the prevention of tropical infectious diseases. Its proprietary Themaxyn technology platform, in-licensed from Paris-based Institute Pasteur, forms the basis of all of the company's vaccine candidates. The company was founded by Erich Tauber in 2009 and is headquartered in Vienna, Austria. | Pharmaceuticals: Major | Chairman | |
Proteus Discovery, Inc.
Proteus Discovery, Inc. BiotechnologyHealth Technology Proteus Discovery, Inc. develops targeted therapeutics for genetically linked diseases. Its technologies include ensemble docking, molecular dynamics, MM-GB/SA and free energy perturbation and computing. The company was founded by Karl Ruping, Justin Boyd and Soumya Ray in 2012 and is headquartered in Cambridge, MA. | Biotechnology | Chief Executive Officer | |
VIR BIOTECHNOLOGY, INC. | Biotechnology | Private Equity Investor | |
Adjuvant Capital LP
Adjuvant Capital LP Investment ManagersFinance Adjuvant Capital LP (Adjuvant Capital) is a private equity and venture capital firm founded in 2018 by Glenn Rockman, Kabeer Aziz and Charlie Petty. The firm is headquartered in New York. | Investment Managers | Consultant / Advisor | |
Revela Biotech LLC
Revela Biotech LLC Medical SpecialtiesHealth Technology Revela Biotech LLC is a company that specializes in next generation immunopet technologies. The company is based in Cambridge, MA. The company works with research institutes and commercial partners to provide advanced imaging solutions to patients. Revela Biotech was founded by Peter McGrath and the CEO is Karl H. Ruping. | Medical Specialties | Chief Executive Officer Founder | |
Barclays Investment Bank | Corporate Officer/Principal |
Statistiques
Internationale
Etats-Unis | 16 |
Autriche | 4 |
Suisse | 2 |
France | 2 |
Canada | 2 |
Sectorielle
Consumer Services | 9 |
Health Technology | 8 |
Finance | 5 |
Electronic Technology | 2 |
Technology Services | 2 |
Opérationnelle
Founder | 8 |
Corporate Officer/Principal | 6 |
Private Equity Investor | 6 |
Consultant / Advisor | 4 |
Director/Board Member | 3 |
Relations les plus connectées
Insiders | |
---|---|
Christian Mandl | 9 |
Karl Ruping | 9 |
R. Michael Raab | 5 |
Peter McGrath | 5 |
Jasdave Chahal | 4 |
- Bourse
- Insiders
- David Nieto
- Connexions Sociétés